GCIA
DOVA

Gabelli & Co Investment Advisers’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-33,000
Closed -$922K – 232
2019
Q3 		$922K Buy
+33,000
New +$535K 0.1% 92

Gabelli & Co Investment Advisers's DOVA Position: Q4 2019 in Review

Gabelli & Co Investment Advisers sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 33,000 shares — an estimated $922K sold.

Gabelli & Co Investment Advisers first reported a position in DOVA in Q3 2019 and held it in 1 quarter. The position peaked at $922K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Gabelli & Co Investment Advisers reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 33,000 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $922K.
  • Gabelli & Co Investment Advisers first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Dova Pharmaceuticals, Inc. Common Stock position peaked at $922K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.